Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Ra Medical Systems, Inc. RMED NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
31/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Ra Medical Systems, Inc. (RMED) — Analyst outlook / Analyst consensus target is. Based on 5 analyst ratings, the consensus is bullish — 2 Buy, 3 Hold.

RMED Analyst Ratings

Hold
5
Ratings
2 Buy
3 Hold
Based on 5 analysts giving stock ratings to Ra Medical Systems, Inc. in the past 3 months
Rating breakdown
Buy
2 40%
Hold
3 60%
40%
Buy
2 analysts
60%
Hold
3 analysts
0%
Sell
0 analysts

People Also View

IRIX
IRIX
IRIDEX Corporation
$1.03
+0.97%
 SINT
SINT
Sintx Technologies, Inc.
$2.80
-2.44%
 TNON
TNON
Tenon Medical, Inc.
$0.81
-1.28%
 TLIS
TLIS
Talis Biomedical Corporation
$2.84
+0.00%
 HSCS
HSCS
Heart Test Laboratories, Inc.
$1.97
-0.76%
 INVO
INVO
INVO Bioscience, Inc.
$0.83
-2.00%
 RSLS
RSLS
ReShape Lifesciences Inc.
$3.92
+22.50%
 BBLG
BBLG
Bone Biologics Corporation
$1.26
+2.44%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message